Editor profile
Managing Editor, Digital Health
Julian Sterling analyzes the evolution of global telemedicine platforms and health data management systems. He focuses on the digital transformation of patient care delivery.
julian.sterling@medtechdaily.orgIn-depth analysis of the current status of AI realizing commercial value in the healthcare sector. This article examines how AI drives returns on investment in core fields such as medical imaging and drug discovery from the perspectives of enterprise applications, technological trends, and market impact.
In-depth analysis of how the medical industry is moving AI from experimentation to implementation, exploring the driving forces behind generative AI and open-source models, as well as the return on investment (ROI) for medical AI in core fields such as imaging and drug discovery.
In-depth analysis of how AI, surgical robots, and remote patient monitoring are reshaping the medical device, digital health, and medical innovation sectors. Explore the profound impact of these technologies on clinical workflows, market competition, and the regulatory environment.
In-depth analysis of the regulatory challenges brought by AI in digital health and medical devices. This paper discusses the risks of AI whitewashing, FDA guidance on new methodologies, and the impact of global data privacy policies on Biotech Innovation and Digital Health platforms.
In-depth analysis of core trends in biotechnology and life sciences for 2026. Covering the application of AI in drug discovery, the clinical implementation of gene editing, the explosion of synthetic biology, and major shifts in global regulatory frameworks and capital flows.
Analyze the gap between the recognition of wearable device data by global physicians and its actual clinical application. Discuss the structural challenges in promoting the integration of Digital Health and AI Healthcare, including data trust, regulatory frameworks, and workflow reshaping.
In-depth analysis of the core applications of medical AI in diagnostic assistance, drug discovery, and digital health platforms, exploring its driving role in the medical equipment and health technology industries, and examining regulatory challenges.
In-depth analysis of the scale, driving factors, and future trends of the global healthcare digital transformation market. Exploring how AI in healthcare, digital health platforms, and medical device innovation are reshaping the healthcare service ecosystem.
Based on a joint survey by AMA and Medscape, this article analyzes the current clinical use of wearable data among global physicians and the barriers to its integration, exploring the impact of key factors such as payment, regulation, and workflow on the medical technology market.
According to a Future Market Insights report, the global medical IoT market is expected to reach US$280.5 billion by 2026, increasing to US$1,164.8 billion by 2036, with a compound annual growth rate of 15.3%. Hardware accounts for 46%, telemedicine for 32%, and India is the fastest-growing market.
The global clinical trial market size is expected to reach $143.46 billion by 2033, with AI and decentralized models reshaping the drug development landscape.
This article reviews the evolution of digital health from early mobile health to the present, analyzes how technology is reshaping the healthcare industry, and looks forward to future trends in medical innovation in the AI era.
Based on a systematic review of global AI medical device regulation and research from 2015 to 2025, this paper analyzes the regulatory pathways of the United States, the European Union, China, Japan, and South Korea, and explores how policies affect the medical technology industry.
According to the latest Healthcare Foresights report, the global healthcare digital transformation market is expected to reach $270.9 billion by 2035, with a compound annual growth rate of 14.13%. This article analyzes how key technologies such as AI, cloud platforms, and telemedicine are driving transformation in the healthcare industry, and explores market opportunities and challenges.
In 2026, the biotech and life sciences industry reaches a critical turning point. From AI-driven drug discovery to clinical breakthroughs in gene editing, from regulatory reforms to global capital flows, these 26 trends are reshaping the future of medical innovation.
From FDA to the EU AI Act: A Decade of Evolution and Industry Impact of AI Medical Device Regulatory Policies Across the World's Five Major Economies.
This article analyzes the application of AI in the healthcare industry from an industrial perspective, focusing on how CRM platforms represented by Salesforce drive digital transformation in healthcare through AI agents, data integration, and patient relationship management, while also exploring development trends over the next 3-5 years.
The U.S. FDA has selected Dexcom as the first participant in the TEMPO digital health device pilot. The AI-driven blood glucose management program will be granted exemption from certain premarket approval requirements, while collecting real-world data through Medicare.
The self-disinfecting medical device market is rapidly expanding at a compound annual growth rate of 14%, driven by rising hospital infection rates, a surge in surgical volumes, and increasing healthcare expenditure. This article analyzes market dynamics, key technology trends, and regional competitive landscape.
AI is reshaping the healthcare industry, from diagnostic assistance to patient management, with technology implementation accelerating. This article analyzes key trends, market impacts, and future challenges.